Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2779
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)